If you did some research you would see that RAC is fully funded through to close to the end of the decade from existing shareholder support ($1.25 piggyback options) and the Australian tax payers (i.e. R&D tax rebate).
I have always been of the belief that if you treat your shareholders with respect and look after their interest that they will support the company. While some biotechs treat their retail shareholders as dumb farm animals, Race is not one of these.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)